Latest Articles
-
Five for Friday June 28: Celebrating Success in Advancing Medication Use Quality
Patients receiving specialty medications often have complex, high-cost treatment needs, necessitating close management from care teams, including specialty pharmacies. Recognizing this, specialty pharmacy stakeholders have articulated the need for standardized turnaround time (TAT) measurement and reporting to better understand a key aspect of specialty pharmacy quality. In 2022, we launched the PQA Specialty Pharmacy Turnaround Time […] -
Piloting the PQA Specialty Pharmacy Turnaround Time Quality Measure
The use of specialty medicine has grown rapidly in recent decades, fueling parallel growth in the number of specialty pharmacies that serve patients who are prescribed specialty medications. Patients receiving specialty medications often have complex, high-cost treatment needs, necessitating close management from care teams, including specialty pharmacies. Specialty pharmacies dispense medications, for which timely initiation of […] -
PQA Retires Health Plan Performance Measure for Use of Opioids from Multiple Providers in Persons Without Cancer
Low measure rates and minimal opportunity for improvement informed retirement vote Alexandria, Va. (June 25, 2024) – The Pharmacy Quality Alliance (PQA), through a majority vote of its members, has retired the Use of Opioids from Multiple Providers in Persons Without Cancer (OMP) health plan performance measure. The measure evaluated the percentage of individuals 18 […] -
Diverse Voices in Quality: Binal Patel
Diverse Voices in Quality is a PQA blog series that showcases the successful career paths and experiences of medication use quality professionals from diverse groups at PQA member organizations. A part of PQA’s Diverse Quality Leaders Program, this series celebrates the achievements of our members who reflect our nation’s diversity and provides everyone with insights and inspiration […] -
High-Impact Measurement for Chronic Conditions Helps Avoid Excess Care Costs
-
Five for Friday June 14: Celebrating Success in Advancing Medication Use Quality
PQA, in partnership with Inovalon, is evaluating the impact of the Medicare out-of-pocket cost cap for insulin on persistence to basal insulin. A large body of evidence has linked improved medication adherence to improved outcomes in patients with diabetes. However, the cost of insulin presents a significant burden to patients, contributing to a decrease in medication-taking behavior. The […] -
PQA and Inovalon Evaluating Impact of Medicare Cost Cap for Insulin on Patient Persistence
Analysis Will Study Effects of IRA Provisions to Improve Access to Basal Insulin Alexandria, Va. (June 5, 2024) – The Pharmacy Quality Alliance (PQA) in partnership with Inovalon is evaluating the impact of the Medicare out-of-pocket cost cap for insulin on persistence to basal insulin. The analysis will use the PQA-endorsed Persistence to Basal Insulin(PST-INS) […] -
Five for Friday May 31: Celebrating Success in Advancing Medication Use Quality
More than 400 leaders from PQA member organizations attended the 2024 PQA Annual Meeting, May 14-16, to network, engage and gain actionable insights. During the meeting, PQA presented eight Medicare plan contracts with a PQA Laura Cranston Excellence in Quality or Quality Improvement Award and awarded top posters from the 2024 PQA Annual Meeting Poster Session, sponsored by PQS. Learn […] -
Advancing the Quality of Oral Anticancer Medication Use
Oral anticancer medications (OAMs) are a growing and important tool in the fight against cancer. More than 120 FDA-approved OAMs were used in clinical practice in 2022, and OAMs represent more than one-third of cancer medications in the development pipeline. The quality of OAM use impacts clinical care, care coordination, patient safety and outcomes – […] -
Quality Professionals Gather at the 2024 PQA Annual Meeting
PQA members and health quality professionals gathered in Baltimore, Md., May 14-16, for the 2024 PQA Annual Meeting. For these three days, health care executives and quality professionals from pharmacies, health plans, health care providers, pharmacy benefit managers, biopharmaceutical companies, technology vendors, government agencies and more addressed top issues and emerging trends in medication quality, measure development […]
PQA In the News
-
PQA’s quality roadmap: Micah Cost on the next era of medication quality measurement
-
Focusing Quality Measures on Outcomes and Patient Experience
-
Value-Based Pharmacy Model Helps Boost Care Quality
-
PQA presents Quality Awards to 10 Medicare plan contracts for high achievement in medication quality measures
-
Pharmacy Quality Alliance Elects 2026 Board of Directors and Executive Committee
Request a PQA Expert
For members of the media or who wish to speak with an expert source on quality, please contact:
Download Media Materials
For PQA logos, images and other communications collateral, please contact:
Leading the Conversation About Medication Quality
“Quality medication use is essential to value-based, person-centered care. Through connection, collaboration, and consensus, PQA drives improvements to promote the best medication-related care and outcomes for patients.”
Micah Cost, PharmD, MS, CAE, Chief Executive Officer
Strategic Media Partnerships
PQA partners with a variety of media to provide news, insights and opinions.
Stay Informed
Get the latest PQA news and events delivered to your inbox.